Michael Bruce
Directeur Général chez Exo Therapeutics, Inc.
Postes actifs de Michael Bruce
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Exo Therapeutics, Inc.
 Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Exo Therapeutics, Inc. engages in production of drugs. It has developed a small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes (exo-sites) that are not evolutionarily conserved. The company was founded by David R. Liu and Alan Saghatelian and is headquartered in Boston, MA. | Directeur Général | 01/02/2020 | - |
Historique de carrière de Michael Bruce
Anciens postes connus de Michael Bruce
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| KALEIDO BIOSCIENCES, INC. | Corporate Officer/Principal | 01/10/2017 | 01/02/2020 |
| CRISPR THERAPEUTICS AG | Corporate Officer/Principal | 01/01/2015 | 01/01/2017 |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Corporate Officer/Principal | 01/01/2003 | 01/01/2015 |
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2003 | 01/01/2015 |
Formation de Michael Bruce
| Williams College | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Suisse | 2 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| CRISPR THERAPEUTICS AG | Health Technology |
| KALEIDO BIOSCIENCES, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Exo Therapeutics, Inc.
Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Exo Therapeutics, Inc. engages in production of drugs. It has developed a small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes (exo-sites) that are not evolutionarily conserved. The company was founded by David R. Liu and Alan Saghatelian and is headquartered in Boston, MA. | Health Technology |
- Bourse
- Insiders
- Michael Bruce
- Expérience
